Thomas Nösslinger
Thomas Nösslinger publishes mostly in Hematology, Genetics and Pathology and Forensic Medicine, on topics such as Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research and Lymphoma Diagnosis and Treatment.
- World rank
- #1,836,492 of 7,710,434 ranked researchers
- Rank in Austria
- #11,058 of 43,330
- Works
- 102
- Citations
- 4k
- Citations per work
- 39.2
What does Thomas Nösslinger research?
Thomas Nösslinger's work is mostly in Medicine (70%), Biochemistry, Genetics and Molecular Biology (8%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences7270.5%
- Medicine7270.5%
- Everything else1817.8%
- Life Sciences1211.7%
- 1Hematology27% of their works
- 2Genetics23% of their works
- 3Pathology and Forensic Medicine13% of their works
- 4Oncology8% of their works
- 5Molecular Biology8% of their works
- 6Immunology4% of their works
Research topics
- Acute Myeloid Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Lymphoma Diagnosis and Treatment
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Myeloid Leukemia Treatments
- Multiple Myeloma Research and Treatments
- Retinoids in leukemia and cellular processes
- CNS Lymphoma Diagnosis and Treatment
Which keywords describe Thomas Nösslinger's research?
The keywords of their largest research topics: Prognostic Factors, Rituximab, Acute Myeloid Leukemia, AML, Chronic Lymphocytic Leukemia, Genomic Aberrations, Classification and Lymphoma.
- Chemotherapy
- Acute Promyelocytic Leukemia
- Diagnosis Criteria
- BCR-ABL
- JAK2 Mutation
- Lymphoma
- Genomic Aberrations
- Acute Myeloid Leukemia
- Rituximab
- Prognostic Factors
- AML
- Chronic Lymphocytic Leukemia
- Classification
- Prognostic Scoring System
- Myelofibrosis
- Imatinib
- International Myeloma Working Group
- Retinoic Acid
- Primary CNS Lymphoma
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Prognostic Factors932 topics
- Rituximab752 topics
- AML541 topic
- Acute Myeloid Leukemia541 topic
- Chronic Lymphocytic Leukemia391 topic
- Genomic Aberrations391 topic
- Classification361 topic
- Lymphoma361 topic
- Prognostic Scoring System282 topics
- JAK2 Mutation221 topic
- Myelofibrosis221 topic
- BCR-ABL111 topic
- Imatinib111 topic
- Diagnosis Criteria101 topic
- International Myeloma Working Group101 topic
- Acute Promyelocytic Leukemia91 topic
- Retinoic Acid91 topic
- Chemotherapy61 topic
- Primary CNS Lymphoma61 topic
Where does Thomas Nösslinger work?
Thomas Nösslinger's main affiliation in the publication record is Hanusch Hospital, Austria.
How many publications and citations does Thomas Nösslinger have?
OpenAlex counts 102 works and 4,001 citations for Thomas Nösslinger, an h-index of 26, ranking #1,836,492 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Thomas Nösslinger. Posts are plain text and can be reported.